Tianjin Zhong Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million | The Edge Singapore
2021-04-29T09:45:37-04:00April 29th, 2021|
Related Posts
-
Gold prices set for weekly decline ahead of US inflation data
April 26th, 2024 -
Huawei’s new phone sports latest version of made-in-China chip
April 26th, 2024 -
Workplace flexibility on rise as Singapore pushes for four-day week
April 26th, 2024 -
Meta’s earnings flop sparks US$400 billion sell-off in tech stocks
April 26th, 2024